Jersey has been chosen to run a clinical medical trial to test new technology it is hoped will lead to improved patient care.

Cefazolin demonstrated equivalent survival rates and lower kidney injury risks compared to standard antistaphylococcal penicillins in a new trial.

Clinical data, regulatory milestones, AI-assisted discovery platforms, and expanding development pipelines are creating a steady stream of catalysts that investors will be watching closely during the ...

Protocol design does not struggle in the protocol. It struggles in the transition to trial, when assumptions embedded in the ...

Glenmark Specialty S.A, a wholly owned subsidiary of Glenmark Pharmaceuticals (Glenmark) announced the advancement of its multi-country Phase 3 clinical trial for Trastuzumab rezetecan (SHR-A1811), a ...

BCC Research examines how AI is streamlining patient recruitment, optimizing trial design, enabling remote monitoring and ...

U.S. lawmakers have opened a national security probe into Eli Lilly's (NYSE:LLY) clinical trial activities in China. The ...

That would be an impressive run if it could get there soon.

Upadacitinib improved fistula outcomes in adults with perianal Crohn’s disease, with the strongest benefit reported among those who had no history of tumor necrosis factor inhibition use and those ...

JenaValve today announced new clinical findings for its Trilogy TAVR system shared last week at the New York Valves 2026 ...

Independent DSMB identifies no safety concerns and recommends continuation of the clinical trial being conducted at the Icahn School of Medicine at Mount Sinai ...

More adults with chronic inducible urticaria receiving remibrutinib vs. placebo achieved complete symptom control at week 12, ...